Qinwen Ge

Qinwen Ge

Auto-generated profile, based on publicly available information

Qinwen Ge

Institute of Orthopaedics and Traumatology of Zhejiang Province Hangzhou Zhejiang China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
QGQinwen Ge
Qinwen Ge
ZSZhenyu Shi
Zhenyu Shi
KZKai-Ao Zou
Kai-Ao Zou
JYJun Ying
Jun Ying
JCJiali Chen
Jiali Chen
HJHongting Jin
Hongting Jin
TGF-β signaling is crucial for modulating osteoarthritis (OA), and protein phosphatase magnesium–dependent 1A (PPM1A) has been reported as a phosphatase of SMAD2 and regulates TGF-β signaling, while the role of PPM1A in cartilage homeostasis and OA development remains largely unexplored. In this study, we found increased PPM1A expression in OA chondrocytes and confirmed the interaction between PPM1A and phospho-SMAD2 (p-SMAD2). Importantly, our data show that PPM1A KO substantially protected mice treated with destabilization of medial meniscus (DMM) surgery against cartilage degeneration and subchondral sclerosis. Additionally, PPM1A ablation reduced the cartilage catabolism and cell apoptosis after the DMM operation. Moreover, p-SMAD2 expression in chondrocytes from KO mice was higher than that in WT controls with DMM induction. However, intraarticular injection with SD-208, repressing TGF-β/SMAD2 signaling, dramatically abolished protective phenotypes in PPM1A-KO mice. Finally, a specific pharmacologic PPM1A inhibitor, Sanguinarine chloride (SC) or BC-21, was able to ameliorate OA severity in C57BL/6J mice. In summary, our study identified PPM1A as a pivotal regulator of cartilage homeostasis and demonstrated that PPM1A inhibition attenuates OA progression via regulating TGF-β/SMAD2 signaling in chondrocytes and provided PPM1A as a potential target for OA treatment.

6 April 2026 in Bone & Joint Research
Verified
Journal Article
Open access
PDF file
QGQinwen Ge
Qinwen Ge
ZSZhenyu Shi
Zhenyu Shi
XLXuefeng Li
Xuefeng Li
CWCongzi Wu
Congzi Wu
QSQi Sun
Qi Sun
HJHongting Jin
Hongting Jin
Aims: Patellar luxation can cause abnormal mechanical loading and is a leading cause of patellofemoral joint damage, however its contribution to femoral-tibial joint damage is poorly elucidated. In this study, we sought to investigate the role of patellar luxation in the femoral-tibial joint in both mice and humans. Methods: In this study, we generated a patellar luxation mouse model based on the standard operating procedure of destabilization of the medial meniscus (DMM) surgery which mimics osteoarthritis (OA). Then phenotypes including gait analysis, osteophyte formation, aberrant subchondral bone remodelling, cartilage degeneration, and synovitis of femoral-tibial joint were evaluated in vivo at eight weeks after surgery. Additionally, we also performed a retrospective study to investigate femoral-tibial joint characteristics in 18 patients with post-traumatic OA or recurrent patellar luxation. Results: We found that patellar luxation caused abnormal gait and augmented osteophyte outgrowth around the tibial plateau and patella. Furthermore, micro-CT analysis showed that mice treated with patellar luxation operation exhibited aberrant subchondral bone remodelling. Intriguingly, according to Safranin-O/Fast Green staining, mice with patellar luxation showed better articular cartilage integrity and less cartilage proteoglycan damage in the medial compartment of the femoral-tibial joint. Moreover, either patellar luxation operation or DMM surgery promoted the expression of TNF-α and F4/80 in synovium tissue. However, mice subjected to patellar luxation exhibited aggressive cartilage erosion in the lateral compartment of the knee joint. In addition, the clinical study showed that patellar luxation was associated with lateral cartilage degeneration of the femoral-tibial joint. Conclusion: This study confirmed that lateral patellar luxation induced subchondral bone osteopenia, promoted osteophyte formation as well as synovial inflammation, and caused lateral cartilage rather than medial cartilage degeneration in the femoral-tibial joint. Cite this article: Bone Joint Res 2026;15(4):363–374.

22 July 2026 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
JLJiangyuan Liu
Jiangyuan Liu
KCKairui Chen
Kairui Chen
JWJingyuan Wen
Jingyuan Wen
QZQinghe Zeng
Qinghe Zeng
LCLiangyan Cheng
Liangyan Cheng
YWYungang Wu
Yungang Wu
Osteoporosis (OP) is a prevalent skeletal disorder characterized by progressive bone mass loss and deteriorated microarchitecture, in which oxidative stress‐induced mesenchymal stem cell (MSC) dysfunction serves as a core pathogenic mechanism. Yougui Pills (YGPs), a classical traditional Chinese medicine formula, are widely applied in clinical OP management, yet the cellular and molecular mechanisms underlying their anti‐osteoporotic effects remain incompletely defined. This study aimed to elucidate the bone‐protective role of YGPs in OP and explore the underlying mechanism, focusing on oxidative stress modulation in MSCs and the Nrf2/HO‐1 signalling pathway. The bioactive components of YGPs and YGP‐containing serum were characterized via UPLC. In vivo, an ovariectomy (OVX) mouse model was established to evaluate YGPs' effects on bone mass, trabecular microstructure and osteogenesis using micro‐CT, histological and immunohistochemical assays; public GEO datasets were re‐analysed to profile transcriptomic alterations and oxidative stress signatures in OP‐derived MSCs. In vitro, H 2 O 2 was used to induce ROS accumulation and oxidative injury in MSCs, with assessments of cell proliferation, apoptosis, ROS levels, migration and osteogenic differentiation. Network pharmacology and siRNA‐mediated gene silencing were conducted for target prediction and mechanistic validation. In vivo results showed that YGP treatment significantly ameliorated OVX‐induced osteopenia, increased bone mineral density, improved trabecular microstructure, and upregulated osteogenic markers (ALP, OCN, Runx2, COL1A1). Transcriptomic re‐analysis revealed upregulated oxidative stress markers in OP MSCs, consistent with In vitro findings that YGPs attenuated H 2 O 2 ‐triggered ROS overproduction, suppressed apoptosis and ectopic lipid deposition, and enhanced MSC proliferation, migration and osteogenic differentiation. Mechanistically, YGPs activated the Nrf2/HO‐1 signalling axis, while Nrf2 knockdown abrogated YGPs' cytoprotective and pro‐osteogenic effects. In conclusion, YGPs mitigate oxidative stress‐induced MSC dysfunction and promote osteogenesis via the Nrf2/HO‐1 pathway, supporting YGPs as a promising therapeutic candidate for OP.